السوق العالمية للتصوير ما قبل السريري – اتجاهات الصناعة والتوقعات حتى عام 2030

Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Buy Now اشتري الآن Inquire Before Buying استفسر قبل Free Sample Report تقرير عينة مجاني

السوق العالمية للتصوير ما قبل السريري – اتجاهات الصناعة والتوقعات حتى عام 2030

  • Medical Devices
  • Published Report
  • Oct 2023
  • Global
  • 350 الصفحات
  • عدد الجداول: 938
  • عدد الأرقام: 24

>السوق العالمية للتصوير ما قبل السريري، حسب المنتج (الأنظمة والخدمات)، الكواشف (كواشف التصوير الضوئي ما قبل السريري، كواشف التصوير النووي ما قبل السريري، عوامل التباين في التصوير بالرنين المغناطيسي ما قبل السريري، عوامل التباين في الموجات فوق الصوتية ما قبل السريرية، عوامل التباين في التصوير المقطعي المحوسب ما قبل السريري)، التطبيق (البحث والتطوير، اكتشاف الأدوية، التوزيع البيولوجي، اكتشاف الخلايا السرطانية، العلامات الحيوية، وغيرها)، المستخدم النهائي (منظمة أبحاث العقود، شركات الأدوية والتكنولوجيا الحيوية، معاهد البحوث الأكاديمية والحكومية، مركز التشخيص، وغيرها) - اتجاهات الصناعة والتوقعات حتى عام 2030.

سوق التصوير ما قبل السريري

تحليل حجم سوق التصوير ما قبل السريري

السوق العالمية للتصوير ما قبل السريري هي الصناعة التي تعمل على توفير حلول وتقنيات التصوير لإجراء البحوث والتجارب على الحيوانات (القوارض عادةً) في المرحلة ما قبل السريرية لتطوير الأدوية والبحوث الطبية. تعتبر تقنيات التصوير هذه ضرورية لتقييم سلامة وفعالية المرشحين المحتملين للأدوية والعلاجات الطبية قبل تقدمهم إلى التجارب السريرية التي تشمل البشر. يسمح التصوير ما قبل السريري للباحثين وشركات الأدوية بتقييم تأثيرات المرشحين للأدوية على الكائنات الحية قبل الانتقال إلى التجارب البشرية. يساعد هذا في تحديد المشكلات المحتملة وتحسين أنظمة الجرعات والحد من مخاطر الآثار السلبية في المراحل اللاحقة.

سوق التصوير ما قبل السريريسوق التصوير ما قبل السريري

تحلل شركة Data Bridge Market Research أن سوق التصوير ما قبل السريري العالمي من المتوقع أن يصل إلى قيمة 3،299،734.83 ألف دولار أمريكي بحلول عام 2030، بمعدل نمو سنوي مركب قدره 6.3٪ خلال الفترة المتوقعة.

ويغطي تقرير السوق هذا أيضًا تحليل الأسعار والتقدم التكنولوجي بشكل متعمق.

تقرير القياس

تفاصيل

فترة التنبؤ

2023 إلى 2030

سنة الأساس

2022

سنوات تاريخية

2021 (قابلة للتخصيص حتى 2015 - 2020)

وحدات كمية

الإيرادات بالألف دولار أمريكي، والأحجام بالوحدات، والتسعير بالدولار الأمريكي

القطاعات المغطاة

المنتج (الأنظمة والخدمات)، الكواشف (كواشف التصوير الضوئي قبل السريرية، وكواشف التصوير النووي قبل السريرية، وعوامل التباين في التصوير بالرنين المغناطيسي قبل السريرية، وعوامل التباين في الموجات فوق الصوتية قبل السريرية، وعوامل التباين في التصوير المقطعي المحوسب قبل السريرية)، التطبيق (البحث والتطوير، واكتشاف الأدوية، والتوزيع البيولوجي، والكشف عن الخلايا السرطانية، والعلامات الحيوية ، وغيرها)، المستخدم النهائي (منظمة أبحاث العقود، وشركات الأدوية والتكنولوجيا الحيوية، والمعاهد البحثية الأكاديمية والحكومية، ومركز التشخيص، وغيرها)

الدول المغطاة

الولايات المتحدة الأمريكية، كندا، المكسيك، المملكة المتحدة، ألمانيا، إسبانيا، فرنسا، إيطاليا، سويسرا، هولندا، بلجيكا، تركيا، روسيا، بقية أوروبا، الصين، اليابان، أستراليا، كوريا الجنوبية، الهند، سنغافورة، تايلاند، ماليزيا، إندونيسيا، الفلبين، بقية دول آسيا والمحيط الهادئ، البرازيل، الأرجنتين، بقية دول أمريكا الجنوبية، جنوب أفريقيا، الإمارات العربية المتحدة، إسرائيل، المملكة العربية السعودية، مصر، وبقية دول الشرق الأوسط وأفريقيا

الجهات الفاعلة في السوق المشمولة

PerkinElmer Inc.، FUJIFILM Visualsonics, Inc، Bruker، Hologic, Inc، Zeiss International، Agilent Technologies, Inc.، Hamamatsu Photonics KK، SOFIE، Cubresa Inc.، Vieworks Co., Ltd.، LI-COR, Inc.، Aspect Imaging Ltd.، Berthold Technologies GmbH & Co.KG، MILabs BV، TriFoil Imaging، Mediso Ltd.، IVIM Technology Inc.، MR Solutions، Advanced Molecular Vision, Inc، AI4R، Photon وغيرها، وKUB TECHNOLOGIES INC.

تعريف السوق

التصوير ما قبل السريري هو استخدام تقنيات وتقنيات تصوير مختلفة لتصور ودراسة العمليات البيولوجية والأمراض واستجابات الأدوية في نماذج الحيوانات قبل اختبارها على البشر. وهو يتضمن التصوير غير الجراحي للحيوانات، وخاصة القوارض، مثل الفئران والجرذان، لاكتساب رؤى حول الآليات الأساسية للأمراض وتقييم فعالية وسلامة العلاجات المحتملة.

ديناميكيات سوق التصوير ما قبل السريري العالمي

يتناول هذا القسم فهم محركات السوق والمزايا والفرص والقيود والتحديات. وسيتم مناقشة كل هذا بالتفصيل أدناه:

السائقين

  • التقدم التكنولوجي المتزايد في مجال التصوير

يشير التصوير ما قبل السريري إلى استخدام طرق تصوير مختلفة لتصور ودراسة العمليات البيولوجية في الحيوانات قبل التجارب السريرية. تساعد هذه الأنظمة الباحثين على اكتساب نظرة ثاقبة لآليات المرض وتقييم المرشحين المحتملين للأدوية ومراقبة فعالية العلاج. يلعب التقدم التكنولوجي في مجال التصوير دورًا حاسمًا في دفع نمو سوق التصوير ما قبل السريري العالمي.

توفر تقنيات التصوير الحديثة، مثل التصوير بالرنين المغناطيسي عالي الدقة (MRI)، والتصوير المقطعي المحوسب الدقيق (micro-CT)، والموجات فوق الصوتية المتقدمة، للباحثين صورًا أكثر وضوحًا وتفصيلاً للهياكل البيولوجية.

علاوة على ذلك، كانت هناك تحسينات كبيرة في تحليل الصور وخوارزميات معالجة البيانات. تتيح أدوات البرمجيات المتقدمة وخوارزميات التعلم الآلي للباحثين استخراج البيانات الكمية من الصور، وأتمتة مهام معالجة الصور، وتحسين دقة وكفاءة تحليل البيانات. توفر هذه التطورات الوقت وتعزز إمكانية إعادة إنتاج الدراسات السريرية وموثوقيتها.

تعمل تقنيات التصوير عالية الدقة وأنظمة التصوير المتعددة الوسائط وخوارزميات تحليل الصور المتقدمة على تعزيز قدرات التصوير ما قبل السريري وتمكين الباحثين من اكتساب رؤى أعمق حول آليات المرض. وبالتالي، فإن التقدم في تكنولوجيا التصوير يدفع نمو سوق التصوير ما قبل السريري العالمي.

  • زيادة عدد الاستثمارات والتمويل في مجال البحث والتطوير

إن العدد المتزايد من الاستثمارات والتمويل في مجال البحث والتطوير يشكل محركًا مهمًا لنمو سوق التصوير ما قبل السريري العالمي. وتخصص المنظمات موارد كبيرة لتطوير تقنيات التصوير ودعم مبادرات البحث المبتكرة مع تزايد أهمية التصوير ما قبل السريري في اكتشاف الأدوية وتطويرها.

إن الاستثمارات والتمويل في مجال البحث والتطوير تمكن من تطوير طرق وتقنيات جديدة للتصوير ما قبل السريري. ويسهل هذا الدعم المالي تحسين أنظمة التصوير والبرامج والأجهزة، مما يؤدي إلى تحسين جودة الصورة ودقتها وحساسيتها. وتمكن هذه التطورات الباحثين من الحصول على معلومات أكثر دقة وتفصيلاً حول العمليات البيولوجية وآليات المرض واستجابات العلاج، مما يدفع نمو سوق التصوير ما قبل السريري.

بالإضافة إلى ذلك، تساهم التمويلات والاستثمارات في توسيع مرافق وبنية التصوير قبل السريرية. يمكن لمؤسسات البحث وشركات الأدوية إنشاء مراكز تصوير قبل السريرية مخصصة أو ترقية المرافق القائمة، مما يضمن الوصول إلى أحدث معدات التصوير والخبرات. يعزز تطوير البنية الأساسية هذا التعاون، ويسرع البحث، ويجذب المواهب المتميزة، مما قد يدفع نمو سوق التصوير قبل السريرية.

وعلاوة على ذلك، تدعم الاستثمارات والتمويل الدراسات البحثية قبل السريرية التي تستخدم تقنيات التصوير. وتوفر شركات الأدوية والمؤسسات الأكاديمية والهيئات الحكومية الدعم المالي للتجارب قبل السريرية، مما يمكن الباحثين من التحقيق في سلامة وفعالية وآلية عمل المرشحين العلاجيين المحتملين. وتولد هذه الدراسات بيانات قيمة يمكن أن تفيد تصميمات التجارب السريرية وتساعد في تطوير علاجات جديدة، مما يدفع الطلب على تقنيات التصوير قبل السريرية.

علاوة على ذلك، يعمل التمويل والاستثمار في البحث والتطوير أيضًا على تعزيز ترجمة أبحاث التصوير قبل السريرية إلى تطبيقات سريرية. يمكن للدراسات قبل السريرية الناجحة جذب المزيد من الاستثمارات والشراكات، مما يؤدي إلى تطوير تقنيات وتقنيات التصوير للاستخدام البشري. يعمل هذا التوسع في تطبيقات التصوير السريري على تعزيز سوق التصوير قبل السريرية.

ومن ثم، فإن العدد المتزايد من الاستثمارات والتمويل في مجال البحث والتطوير يشكل محركًا مهمًا لنمو سوق التصوير ما قبل السريري العالمي.

سوق التصوير ما قبل السريري

فرصة

  • تزايد استخدام أنظمة التصوير للأغراض السريرية

تبحث صناعات الأدوية والتكنولوجيا الحيوية باستمرار عن مرشحين جدد للأدوية لتلبية الاحتياجات الطبية غير الملباة. يسمح التصوير قبل السريري بفهم أكثر شمولاً للمرشحين المحتملين للأدوية من خلال تصور تأثيراتهم على الكائنات الحية. يساعد هذا في تحديد المرشحين الواعدين واستبعاد أولئك الذين لديهم خصائص غير مواتية في وقت مبكر من عملية تطوير الدواء، مما يوفر الوقت والموارد. يتطلب التحول نحو الطب الشخصي فهمًا أكثر شمولاً لظروف المرضى الأفراد. يمكن استخدام التصوير قبل السريري لتقييم تباين الأمراض وتصميم أساليب العلاج، مما يؤدي إلى علاجات أكثر فعالية.

إن تقنيات التصوير ما قبل السريرية غير جراحية أو قليلة التدخل بشكل عام، وهو ما يعود بالفائدة على الحيوانات المستخدمة في الأبحاث ودقة البيانات التي يتم جمعها. وتتيح هذه الطبيعة غير الجراحية إجراء دراسات طولية، مما يقلل الحاجة إلى التضحية بالحيوانات في نقاط زمنية متعددة.

ومن ثم، فإن الاعتماد المتزايد على أنظمة التصوير للأغراض السريرية المسبقة قد يسمح بنمو السوق في الفترة المتوقعة.

ضبط النفس / التحدي

  • إطار تنظيمي صارم للموافقة على المنتجات

لقد وضعت الهيئات التنظيمية في جميع أنحاء العالم إرشادات ومتطلبات صارمة للموافقة على منتجات التصوير ما قبل السريرية، والتي يمكن أن تخلق حواجز أمام الشركات في السوق وهي عامل تقييدي كبير على نمو سوق التصوير ما قبل السريرية العالمية.

لقد طبقت الهيئات التنظيمية مثل إدارة الغذاء والدواء الأمريكية (FDA) ووكالة الأدوية الأوروبية (EMA) معايير صارمة للموافقة على المنتجات لضمان سلامة المرضى وفعالية منتجات التصوير قبل السريرية. غالبًا ما تتضمن هذه المعايير اختبارات ما قبل السريرية المكثفة، وتقديم البيانات، والالتزام بإرشادات ممارسات المختبرات الجيدة (GLP).

إن عملية التنظيم الخاصة بمنتجات التصوير قبل السريرية تستغرق وقتاً طويلاً وتكلف مبالغ باهظة. إذ تجري الشركات دراسات شاملة لإثبات سلامة وفعالية منتجاتها، وهو ما يتطلب استثماراً كبيراً في البحث والتطوير. بالإضافة إلى ذلك، تتطلب عملية تقديم الطلبات التنظيمية توثيقاً مكثفاً وتحليلاً للبيانات والتفاعل مع السلطات التنظيمية، وكل هذا يضيف إلى العبء المالي والوقتي.

وعلاوة على ذلك، قد تختلف المتطلبات التنظيمية الصارمة عبر مناطق مختلفة، مما يخلق تحديات إضافية للشركات العاملة في الأسواق العالمية. ويتعين على الشركات أن تتنقل بين المشهد المعقد للموافقات التنظيمية في بلدان مختلفة، وهو ما قد يؤدي إلى تأخير إطلاق المنتجات وزيادة تكاليف الامتثال.

ومن ثم، فإن الإطار التنظيمي الصارم للموافقة على المنتجات يشكل قيدًا كبيرًا على نمو سوق التصوير ما قبل السريري العالمي.

نطاق سوق التصوير ما قبل السريري العالمي

ينقسم سوق التصوير ما قبل السريري العالمي إلى أربعة قطاعات بارزة بناءً على المنتج والمواد الكيميائية والتطبيق والمستخدم النهائي. سيساعدك النمو بين هذه القطاعات على تحليل قطاعات النمو الضئيلة في الصناعات وتزويد المستخدمين بنظرة عامة قيمة على السوق ورؤى السوق لمساعدتهم على اتخاذ قرارات استراتيجية لتحديد تطبيقات السوق الأساسية.

منتج

  • الأنظمة
  • خدمات

على أساس المنتج، يتم تقسيم السوق إلى أنظمة وخدمات.

الكواشف

  • كواشف التصوير الضوئي قبل السريرية
  • كواشف التصوير النووي قبل السريرية
  • عوامل التباين في التصوير بالرنين المغناطيسي قبل السريرية
  • عوامل التباين بالموجات فوق الصوتية قبل السريرية
  • عوامل التباين في التصوير المقطعي المحوسب قبل السريري

على أساس الكواشف، يتم تقسيم السوق إلى كواشف التصوير الضوئي قبل السريرية، وكواشف التصوير النووي قبل السريرية، وعوامل التباين في التصوير بالرنين المغناطيسي قبل السريرية، وعوامل التباين في الموجات فوق الصوتية قبل السريرية ، وعوامل التباين في التصوير المقطعي المحوسب قبل السريرية .

طلب

  • البحث والتطوير
  • اكتشاف الأدوية
  • التوزيع الحيوي
  • الكشف عن الخلايا السرطانية
  • المؤشرات الحيوية
  • آحرون

على أساس التطبيق، يتم تقسيم السوق إلى البحث والتطوير، واكتشاف الأدوية، والتوزيع البيولوجي، واكتشاف الخلايا السرطانية، والعلامات الحيوية، وغيرها.

المستخدم النهائي

  • منظمة أبحاث العقود
  • شركات الأدوية والتكنولوجيا الحيوية
  • المعاهد البحثية الأكاديمية والحكومية
  • مركز التشخيص
  • آحرون

على أساس المستخدم النهائي، يتم تقسيم السوق إلى منظمة أبحاث تعاقدية، وشركات الأدوية والتكنولوجيا الحيوية، والمعاهد البحثية الأكاديمية والحكومية، ومراكز التشخيص، وغيرها.

سوق التصوير ما قبل السريري

تحليل/رؤى إقليمية لسوق التصوير ما قبل السريري العالمي

يتم تحليل سوق التصوير ما قبل السريري العالمي وتوفير رؤى حجم السوق والاتجاهات حسب البلد والمنتج والكواشف والتطبيق والمستخدم النهائي.

الدول المشمولة في تقرير السوق هذا هي الولايات المتحدة وكندا والمكسيك وألمانيا وفرنسا والمملكة المتحدة وإيطاليا وإسبانيا وروسيا وتركيا وبلجيكا وهولندا وسويسرا وبقية أوروبا واليابان والصين وكوريا الجنوبية والهند وأستراليا وسنغافورة وتايلاند وماليزيا وإندونيسيا والفلبين وبقية دول آسيا والمحيط الهادئ والبرازيل والأرجنتين وبقية دول أمريكا الجنوبية وجنوب أفريقيا والمملكة العربية السعودية والإمارات العربية المتحدة ومصر وإسرائيل وبقية دول الشرق الأوسط وأفريقيا.

ومن المتوقع أن تهيمن أمريكا الشمالية على السوق بحصة سوقية أكبر بسبب الطلب المتزايد على أجهزة التصوير. ومن المتوقع أن تهيمن الولايات المتحدة على منطقة أمريكا الشمالية بسبب التقدم التكنولوجي المتزايد. ومن المتوقع أن تهيمن ألمانيا على منطقة أوروبا بسبب التبني المتزايد لأنظمة التصوير. ومن المتوقع أن تهيمن اليابان على منطقة آسيا والمحيط الهادئ بسبب انتشار الاضطرابات العصبية المتزايد.

يقدم قسم الدولة في التقرير أيضًا عوامل فردية مؤثرة على السوق والتغيرات في تنظيم السوق التي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة المصب والمصب، والاتجاهات الفنية، وتحليل قوى بورتر الخمس، ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. أيضًا، يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير التعريفات الجمركية المحلية، وطرق التجارة أثناء تقديم تحليل تنبؤي لبيانات الدولة.

سوق التصوير ما قبل السريري

تحليل المنافسة وحصة السوق العالمية للتصوير ما قبل السريري

يوفر المشهد التنافسي العالمي لسوق التصوير ما قبل السريري تفاصيل عن المنافسين. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المولدة، وإمكانات السوق، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. تتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بالسوق.

بعض اللاعبين الرئيسيين في السوق الذين يعملون في سوق التصوير ما قبل السريري العالمي هم PerkinElmer Inc. و FUJIFILM Visualsonics، Inc، و Bruker، و Hologic، Inc.، و Zeiss International، و Agilent Technologies، Inc.، و Hamamatsu Photonics KK، و SOFIE، و Cubresa Inc.، و Vieworks Co.، Ltd.، و LI-COR، Inc.، و Aspect Imaging Ltd.، و Berthold Technologies GmbH & Co.KG، و MILabs BV، و TriFoil Imaging، و Mediso Ltd.، و IVIM Technology Inc.، و MR Solutions، و Advanced Molecular Vision، Inc، و AI4R، و Photon وما إلى ذلك، و KUB TECHNOLOGIES INC. وغيرها.


SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
طلب التجريبي

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL PRECLINICAL IMAGING MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT SEGMENT LIFELINE CURVE

2.8 MARKET END USER COVERAGE GRID

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 STRATEGIC INITIATIVES

5 REGULATORY FRAMEWORK

5.1 REGULATORY SCENARIO IN U.S.

5.2 REGULATORY SCENARIO IN AUSTRALIA

5.3 REGULATORY SCENARIO IN EUROPE

5.4 REGULATORY SCENARIO IN SOUTH AFRICA

5.5 REGULATORY SCENARIO IN BRAZIL

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING TECHNOLOGY ADVANCEMENT IN THE FIELD OF IMAGING

6.1.2 INCREASING NUMBER OF INVESTMENTS AND FUNDING IN RESEARCH AND DEVELOPMENT

6.1.3 INCREASING INCIDENCE OF CHRONIC DISEASES

6.2 RESTRAINTS

6.2.1 STRINGENT REGULATORY FRAMEWORK FOR PRODUCT APPROVAL

6.2.2 HIGH INSTALLATION AND OPERATIONAL COST OF PRECLINICAL IMAGING SYSTEMS

6.3 OPPORTUNITIES

6.3.1 INCREASING ADOPTION OF IMAGING SYSTEMS FOR PRECLINICAL PURPOSE

6.3.2 GROWING DEMAND FOR NON-INVASIVE SMALL-ANIMAL IMAGING METHODS

6.4 CHALLENGES

6.4.1 LACK OF SKILLED PROFESSIONALS FOR THE EFFECTIVE UTILIZATION OF PRECLINICAL IMAGING SYSTEMS

6.4.2 INTEGRATION OF IMAGING DEVICES WITH OTHER TECHNOLOGIES

7 GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT

7.1 OVERVIEW

7.2 SYSTEMS

7.2.1 OPTICAL IMAGING SYSTEMS

7.2.1.1 BIOLUMINESCENCE/FLUORESCENCE IMAGING SYSTEMS

7.2.1.2 STANDALONE FLUORESCENCE IMAGING SYSTEMS

7.2.1.3 OPTICAL + X-RAY/OPTICAL + CT

7.2.2 PRECLINICAL NUCLEAR IMAGING SYSTEMS

7.2.2.1 MICRO-POSITRON EMISSION TOMOGRAPHY (PET) SYSTEMS

7.2.2.2 MICRO-SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) SYSTEMS

7.2.2.3 TRIPRODUCT (SPECT/PET/CT) SYSTEMS

7.2.3 MICRO-MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS

7.2.4 MICRO-COMPUTED TOMOGRAPHY (CT) SYSTEMS

7.2.5 MICRO-ULTRASOUND SYSTEMS

7.2.6 PRECLINICAL PHOTOACOUSTIC IMAGING SYSTEMS

7.2.7 PRECLINICAL MAGNETIC PARTICLE IMAGING (MPI) SYSTEMS

7.2.8 MAGNETIC RESONANCE SPECTROSCOPY IMAGING (MRSI)

7.3 SERVICES

8 GLOBAL PRECLINICAL IMAGING MARKET, BY REAGENTS

8.1 OVERVIEW

8.2 PRECLINICAL OPTICAL IMAGING REAGENTS

8.2.1 BIOLUMINESCENT IMAGING REAGENTS

8.2.2 FLUORESCENT IMAGING REAGENTS

8.3 PRECLINICAL NUCLEAR IMAGING REAGENTS

8.3.1 PRECLINICAL PET TRACERS

8.3.2 PRECLINICAL SPECT PROBES

8.4 PRECLINICAL MRI CONTRAST AGENTS

8.4.1 GADOLINIUM-BASED PRECLINICAL MRI CONTRAST AGENTS

8.4.2 MANGANESE-BASED PRECLINICAL MRI CONTRAST AGENTS

8.4.3 IRON-BASED PRECLINICAL MRI CONTRAST AGENTS

8.5 PRECLINICAL ULTRASOUND CONTRAST AGENTS

8.6 PRECLINICAL CT CONTRAST AGENTS

8.6.1 IODINE-BASED PRECLINICAL CT CONTRAST AGENTS

8.6.2 BARIUM-BASED PRECLINICAL CT CONTRAST AGENTS

8.6.3 GOLD NANOPARTICLES

8.6.4 GASTROGRAFIN-BASED PRECLINICAL CT CONTRAST AGENTS

9 GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 RESEARCH AND DEVELOPMENT

9.3 DRUG DISCOVERY

9.4 BIO-DISTRIBUTION

9.5 CANCER CELL DETECTION

9.6 BIO-MARKERS

9.7 OTHERS

10 GLOBAL PRECLINICAL IMAGING MARKET, BY END USER

10.1 OVERVIEW

10.2 CONTRACT RESEARCH ORGANIZATION

10.3 PHARMACEUTICAL & BIOTECH COMPANIES

10.4 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

10.5 DIAGNOSTICS CENTER

10.6 OTHERS

11 GLOBAL PRECLINICAL IMAGING MARKET, BY REGION

11.1 OVERVIEW

11.2 NORTH AMERICA

11.3 EUROPE

11.4 ASIA-PACIFIC

11.5 SOUTH AMERICA

11.6 MIDDLE EAST AND AFRICA

12 GLOBAL PRECLINICAL IMAGING MARKET, COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: GLOBAL

12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

12.3 COMPANY SHARE ANALYSIS: EUROPE

12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

13 SWOT ANALYSIS

14 COMPANY PROFILE

14.1 PERKINELMER INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 FUJIFILM VISUALSONICS, INC

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENT

14.3 BRUKER

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENT

14.4 HOLOGIC, INC.

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 ZEISS INTERNATIONAL

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 ADVANCED MOLECULAR VISION, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 PRODUCT PORTFOLIO

14.6.3 RECENT DEVELOPMENTS

14.7 AGILENT TECHNOLOGIES, INC.

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 AI4R

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENT

14.9 ASPECT IMAGING LTD.

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENT

14.1 BERTHOLD TECHNOLOGIES GMBH & CO.KG

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 CUBRESA INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENT

14.12 HAMAMATSU PHOTONICS K.K.

14.12.1 COMPANY SNAPSHOT

14.12.2 REVENUE ANALYSIS

14.12.3 PRODUCT PORTFOLIO

14.12.4 RECENT DEVELOPMENT

14.13 IVIM TECHNOLOGY CORP.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 KUB TECHNOLOGES INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENT

14.15 LI-COR, INC.

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENT

14.16 MEDISO LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENT

14.17 MILABS B.V.

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 MR SOLUTIONS

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT DEVELOPMENT

14.19 PHOTON ETC

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.2 SOFIE

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 TRIFOIL IMAGING

14.21.1 COMPANY SNAPSHOT

14.21.2 PRODUCT PORTFOLIO

14.21.3 RECENT DEVELOPMENT

14.22 VIEWORKS CO., LTD.

14.22.1 COMPANY SNAPSHOT

14.22.2 REVENUE ANALYSIS

14.22.3 PRODUCT PORTFOLIO

14.22.4 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 2 GLOBAL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 3 GLOBAL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 4 GLOBAL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 5 GLOBAL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 6 GLOBAL SERVICES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 7 GLOBAL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 8 GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 9 GLOBAL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 10 GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 11 GLOBAL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 12 GLOBAL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 13 GLOBAL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 14 GLOBAL PRECLINICAL ULTRASOUND CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 15 GLOBAL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 16 GLOBAL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 17 GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 18 GLOBAL RESEARCH AND DEVELOPMENT IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 19 GLOBAL DRUG DISCOVERY IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 20 GLOBAL BIO-DISTRIBUTION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 21 GLOBAL CANCER CELL DETECTION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 22 GLOBAL BIO-MARKERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 23 GLOBAL OTHERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 24 GLOBAL PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 25 GLOBAL CONTRACT RESEARCH ORGANIZATION IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 26 GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 27 GLOBAL ACADEMIC & GOVERNMENT RESEARCH INSTITUTES IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 28 GLOBAL DIAGNOSTICS CENTER IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 29 GLOBAL OTHERS IN PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 30 GLOBAL PRECLINICAL IMAGING MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 31 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 32 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 33 NORTH AMERICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 34 NORTH AMERICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 35 NORTH AMERICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 36 NORTH AMERICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 37 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 38 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 39 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 40 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 41 NORTH AMERICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 42 NORTH AMERICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 43 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 44 NORTH AMERICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 45 NORTH AMERICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 46 NORTH AMERICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 47 NORTH AMERICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 48 NORTH AMERICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 49 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 50 NORTH AMERICA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 51 U.S. PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 52 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 53 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 54 U.S. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 55 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 56 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 57 U.S. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 58 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 59 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 60 U.S. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 61 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 62 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 63 U.S. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 64 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 65 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 66 U.S. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 67 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 68 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 69 U.S. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 70 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 71 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 72 U.S. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 73 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 74 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 75 U.S. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 76 U.S. PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 77 U.S. PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 78 CANADA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 79 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 80 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 81 CANADA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 82 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 83 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 84 CANADA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 85 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 86 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 87 CANADA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 88 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 89 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 90 CANADA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 91 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 92 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 93 CANADA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 94 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 95 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 96 CANADA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 97 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 98 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 99 CANADA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 100 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 101 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 102 CANADA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 103 CANADA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 104 CANADA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 105 MEXICO PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 106 MEXICO SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 107 MEXICO SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 108 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 109 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 110 MEXICO OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 111 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 112 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 113 MEXICO PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 114 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 115 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 116 MEXICO PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 117 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 118 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 119 MEXICO PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 120 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 121 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 122 MEXICO PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 123 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 124 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 125 MEXICO PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 126 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 127 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 128 MEXICO PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 129 MEXICO PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 130 MEXICO PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 131 EUROPE PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 132 EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 133 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 134 EUROPE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 135 EUROPE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 136 EUROPE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 137 EUROPE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 138 EUROPE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 139 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 140 EUROPE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 141 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 142 EUROPE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 143 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 144 EUROPE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 145 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 146 EUROPE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 147 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 148 EUROPE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 149 EUROPE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 150 EUROPE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 151 GERMANY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 152 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 153 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 154 GERMANY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 155 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 156 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 157 GERMANY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 158 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 159 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 160 GERMANY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 161 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 162 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 163 GERMANY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 164 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 165 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 166 GERMANY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 167 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 168 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 169 GERMANY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 170 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 171 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 172 GERMANY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 173 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 174 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 175 GERMANY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 176 GERMANY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 177 GERMANY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 178 FRANCE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 179 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 180 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 181 FRANCE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 182 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 183 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 184 FRANCE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 185 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 186 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 187 FRANCE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 188 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 189 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 190 FRANCE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 191 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 192 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 193 FRANCE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 194 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 195 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 196 FRANCE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 197 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 198 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 199 FRANCE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 200 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 201 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 202 FRANCE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 203 FRANCE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 204 FRANCE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 205 U.K. PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 206 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 207 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 208 U.K. SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 209 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 210 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 211 U.K. OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 212 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 213 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 214 U.K. PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 215 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 216 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 217 U.K. PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 218 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 219 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 220 U.K. PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 221 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 222 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 223 U.K. PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 224 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 225 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 226 U.K. PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 227 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 228 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 229 U.K. PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 230 U.K. PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 231 U.K. PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 232 ITALY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 233 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 234 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 235 ITALY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 236 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 237 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 238 ITALY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 239 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 240 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 241 ITALY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 242 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 243 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 244 ITALY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 245 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 246 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 247 ITALY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 248 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 249 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 250 ITALY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 251 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 252 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 253 ITALY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 254 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 255 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 256 ITALY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 257 ITALY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 258 ITALY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 259 SPAIN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 260 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 261 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 262 SPAIN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 263 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 264 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 265 SPAIN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 266 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 267 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 268 SPAIN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 269 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 270 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 271 SPAIN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 272 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 273 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 274 SPAIN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 275 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 276 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 277 SPAIN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 278 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 279 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 280 SPAIN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 281 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 282 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 283 SPAIN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 284 SPAIN PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 285 SPAIN PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 286 RUSSIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 287 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 288 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 289 RUSSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 290 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 291 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 292 RUSSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 293 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 294 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 295 RUSSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 296 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 297 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 298 RUSSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 299 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 300 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 301 RUSSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 302 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 303 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 304 RUSSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 305 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 306 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 307 RUSSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 308 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 309 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 310 RUSSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 311 RUSSIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 312 RUSSIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 313 TURKEY PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 314 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 315 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 316 TURKEY SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 317 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 318 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 319 TURKEY OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 320 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 321 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 322 TURKEY PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 323 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 324 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 325 TURKEY PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 326 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 327 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 328 TURKEY PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 329 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 330 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 331 TURKEY PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 332 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 333 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 334 TURKEY PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 335 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 336 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 337 TURKEY PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 338 TURKEY PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 339 TURKEY PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 340 BELGIUM PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 341 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 342 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 343 BELGIUM SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 344 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 345 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 346 BELGIUM OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 347 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 348 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 349 BELGIUM PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 350 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 351 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 352 BELGIUM PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 353 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 354 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 355 BELGIUM PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 356 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 357 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 358 BELGIUM PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 359 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 360 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 361 BELGIUM PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 362 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 363 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 364 BELGIUM PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 365 BELGIUM PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 366 BELGIUM PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 367 NETHERLANDS PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 368 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 369 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 370 NETHERLANDS SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 371 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 372 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 373 NETHERLANDS OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 374 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 375 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 376 NETHERLANDS PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 377 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 378 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 379 NETHERLANDS PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 380 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 381 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 382 NETHERLANDS PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 383 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 384 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 385 NETHERLANDS PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 386 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 387 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 388 NETHERLANDS PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 389 NETHERLANDS PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 390 NETHERLANDS PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 391 NETHERLANDS PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 392 NETHERLANDS PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 393 SWITZERLAND PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 394 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 395 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 396 SWITZERLAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 397 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 398 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 399 SWITZERLAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 400 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 401 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 402 SWITZERLAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 403 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 404 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 405 SWITZERLAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 406 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 407 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 408 SWITZERLAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 409 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 410 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 411 SWITZERLAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 412 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 413 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 414 SWITZERLAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 415 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 416 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 417 SWITZERLAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 418 SWITZERLAND PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 419 SWITZERLAND PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 420 REST OF EUROPE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 421 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 422 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 423 ASIA-PACIFIC SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 424 ASIA-PACIFIC SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 425 ASIA-PACIFIC OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 426 ASIA-PACIFIC OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 427 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 428 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 429 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 430 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 431 ASIA-PACIFIC PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 432 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 433 ASIA-PACIFIC PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 434 ASIA-PACIFIC PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 435 ASIA-PACIFIC PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 436 ASIA-PACIFIC PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 437 ASIA-PACIFIC PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 438 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 439 ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 440 CHINA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 441 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 442 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 443 CHINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 444 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 445 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 446 CHINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 447 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 448 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 449 CHINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 450 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 451 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 452 CHINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 453 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 454 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 455 CHINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 456 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 457 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 458 CHINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 459 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 460 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 461 CHINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 462 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 463 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 464 CHINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 465 CHINA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 466 CHINA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 467 JAPAN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 468 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 469 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 470 JAPAN SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 471 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 472 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 473 JAPAN OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 474 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 475 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 476 JAPAN PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 477 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 478 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 479 JAPAN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 480 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 481 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 482 JAPAN PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 483 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 484 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 485 JAPAN PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 486 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 487 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 488 JAPAN PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 489 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 490 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 491 JAPAN PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 492 JAPAN PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 493 JAPAN PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 494 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 495 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 496 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 497 SOUTH KOREA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 498 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 499 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 500 SOUTH KOREA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 501 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 502 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 503 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 504 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 505 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 506 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 507 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 508 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 509 SOUTH KOREA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 510 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 511 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 512 SOUTH KOREA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 513 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 514 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 515 SOUTH KOREA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 516 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 517 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 518 SOUTH KOREA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 519 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 520 SOUTH KOREA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 521 INDIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 522 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 523 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 524 INDIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 525 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 526 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 527 INDIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 528 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 529 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 530 INDIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 531 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 532 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 533 INDIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 534 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 535 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 536 INDIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 537 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 538 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 539 INDIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 540 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 541 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 542 INDIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 543 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 544 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 545 INDIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 546 INDIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 547 INDIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 548 AUSTRALIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 549 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 550 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 551 AUSTRALIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 552 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 553 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 554 AUSTRALIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 555 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 556 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 557 AUSTRALIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 558 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 559 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 560 AUSTRALIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 561 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 562 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 563 AUSTRALIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 564 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 565 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 566 AUSTRALIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 567 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 568 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 569 AUSTRALIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 570 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 571 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 572 AUSTRALIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 573 AUSTRALIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 574 AUSTRALIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 575 SINGAPORE PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 576 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 577 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 578 SINGAPORE SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 579 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 580 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 581 SINGAPORE OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 582 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 583 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 584 SINGAPORE PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 585 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 586 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 587 SINGAPORE PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 588 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 589 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 590 SINGAPORE PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 591 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 592 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 593 SINGAPORE PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 594 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 595 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 596 SINGAPORE PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 597 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 598 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 599 SINGAPORE PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 600 SINGAPORE PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 601 SINGAPORE PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 602 THAILAND PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 603 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 604 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 605 THAILAND SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 606 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 607 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 608 THAILAND OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 609 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 610 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 611 THAILAND PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 612 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 613 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 614 THAILAND PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 615 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 616 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 617 THAILAND PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 618 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 619 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 620 THAILAND PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 621 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 622 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 623 THAILAND PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 624 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 625 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 626 THAILAND PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 627 THAILAND PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 628 THAILAND PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 629 MALAYSIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 630 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 631 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 632 MALAYSIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 633 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 634 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 635 MALAYSIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 636 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 637 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 638 MALAYSIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 639 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 640 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 641 MALAYSIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 642 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 643 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 644 MALAYSIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 645 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 646 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 647 MALAYSIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 648 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 649 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 650 MALAYSIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 651 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 652 MALAYSIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 653 MALAYSIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 654 MALAYSIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 655 INDONESIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 656 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 657 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 658 INDONESIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 659 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 660 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 661 INDONESIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 662 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 663 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 664 INDONESIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 665 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 666 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 667 INDONESIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 668 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 669 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 670 INDONESIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 671 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 672 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 673 INDONESIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 674 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 675 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 676 INDONESIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 677 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 678 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 679 INDONESIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 680 INDONESIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 681 INDONESIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 682 PHILIPPINES PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 683 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 684 PHILIPPINES SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 685 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 686 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 687 PHILIPPINES OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 688 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 689 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 690 PHILIPPINES PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 691 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 692 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 693 PHILIPPINES PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 694 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 695 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 696 PHILIPPINES PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 697 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 698 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 699 PHILIPPINES PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 700 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 701 PHILIPPINES PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 702 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 703 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 704 PHILIPPINES PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 705 PHILIPPINES PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 706 PHILIPPINES PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 707 REST OF ASIA-PACIFIC PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 708 SOUTH AMERICA PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 709 SOUTH AMERICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 710 SOUTH AMERICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 711 SOUTH AMERICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 712 SOUTH AMERICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 713 SOUTH AMERICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 714 SOUTH AMERICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 715 SOUTH AMERICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 716 SOUTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 717 SOUTH AMERICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 718 SOUTH AMERICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 719 SOUTH AMERICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 720 SOUTH AMERICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 721 SOUTH AMERICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 722 SOUTH AMERICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 723 SOUTH AMERICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 724 SOUTH AMERICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 725 SOUTH AMERICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 726 SOUTH AMERICA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 727 SOUTH AMERICA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 728 BRAZIL PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 729 BRAZIL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 730 BRAZIL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 731 BRAZIL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 732 BRAZIL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 733 BRAZIL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 734 BRAZIL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 735 BRAZIL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 736 BRAZIL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 737 BRAZIL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 738 BRAZIL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 739 BRAZIL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 740 BRAZIL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 741 BRAZIL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 742 BRAZIL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 743 BRAZIL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 744 BRAZIL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 745 BRAZIL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 746 BRAZIL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 747 BRAZIL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 748 BRAZIL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 749 BRAZIL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 750 BRAZIL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 751 BRAZIL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 752 BRAZIL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 753 BRAZIL PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 754 BRAZIL PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 755 ARGENTINA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 756 ARGENTINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 757 ARGENTINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 758 ARGENTINA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 759 ARGENTINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 760 ARGENTINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 761 ARGENTINA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 762 ARGENTINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 763 ARGENTINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 764 ARGENTINA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 765 ARGENTINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 766 ARGENTINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 767 ARGENTINA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 768 ARGENTINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 769 ARGENTINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 770 ARGENTINA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 771 ARGENTINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 772 ARGENTINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 773 ARGENTINA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 774 ARGENTINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 775 ARGENTINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 776 ARGENTINA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 777 ARGENTINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 778 ARGENTINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 779 ARGENTINA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 780 ARGENTINA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 781 ARGENTINA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 782 REST OF SOUTH AMERICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 783 MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 784 MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 785 MIDDLE EAST AND AFRICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 786 MIDDLE EAST AND AFRICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 787 MIDDLE EAST AND AFRICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 788 MIDDLE EAST AND AFRICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 789 MIDDLE EAST AND AFRICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 790 MIDDLE EAST AND AFRICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 791 MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 792 MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 793 MIDDLE EAST AND AFRICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 794 MIDDLE EAST AND AFRICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 795 MIDDLE EAST AND AFRICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 796 MIDDLE EAST AND AFRICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 797 MIDDLE EAST AND AFRICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 798 MIDDLE EAST AND AFRICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 799 MIDDLE EAST AND AFRICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 800 MIDDLE EAST AND AFRICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 801 MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 802 MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 803 SOUTH AFRICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 804 SOUTH AFRICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 805 SOUTH AFRICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 806 SOUTH AFRICA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 807 SOUTH AFRICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 808 SOUTH AFRICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 809 SOUTH AFRICA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 810 SOUTH AFRICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 811 SOUTH AFRICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 812 SOUTH AFRICA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 813 SOUTH AFRICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 814 SOUTH AFRICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 815 SOUTH AFRICA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 816 SOUTH AFRICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 817 SOUTH AFRICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 818 SOUTH AFRICA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 819 SOUTH AFRICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 820 SOUTH AFRICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 821 SOUTH AFRICA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 822 SOUTH AFRICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 823 SOUTH AFRICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 824 SOUTH AFRICA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 825 SOUTH AFRICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 826 SOUTH AFRICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 827 SOUTH AFRICA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 828 SOUTH AFRICA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 829 SOUTH AFRICA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 830 SAUDI ARABIA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 831 SAUDI ARABIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 832 SAUDI ARABIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 833 SAUDI ARABIA SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 834 SAUDI ARABIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 835 SAUDI ARABIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 836 SAUDI ARABIA OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 837 SAUDI ARABIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 838 SAUDI ARABIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 839 SAUDI ARABIA PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 840 SAUDI ARABIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 841 SAUDI ARABIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 842 SAUDI ARABIA PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 843 SAUDI ARABIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 844 SAUDI ARABIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 845 SAUDI ARABIA PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 846 SAUDI ARABIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 847 SAUDI ARABIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 848 SAUDI ARABIA PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 849 SAUDI ARABIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 850 SAUDI ARABIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 851 SAUDI ARABIA PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 852 SAUDI ARABIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 853 SAUDI ARABIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 854 SAUDI ARABIA PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 855 SAUDI ARABIA PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 856 SAUDI ARABIA PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 857 U.A.E PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 858 U.A.E SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 859 U.A.E SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 860 U.A.E SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 861 U.A.E OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 862 U.A.E OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 863 U.A.E OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 864 U.A.E PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 865 U.A.E PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 866 U.A.E PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 867 U.A.E PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 868 U.A.E PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 869 U.A.E PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 870 U.A.E PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 871 U.A.E PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 872 U.A.E PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 873 U.A.E PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 874 U.A.E PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 875 U.A.E PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 876 U.A.E PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 877 U.A.E PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 878 U.A.E PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 879 U.A.E PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 880 U.A.E PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 881 U.A.E PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 882 U.A.E PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 883 U.A.E PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 884 EGYPT PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 885 EGYPT SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 886 EGYPT SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 887 EGYPT SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 888 EGYPT OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 889 EGYPT OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 890 EGYPT OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 891 EGYPT PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 892 EGYPT PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 893 EGYPT PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 894 EGYPT PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 895 EGYPT PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 896 EGYPT PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 897 EGYPT PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 898 EGYPT PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 899 EGYPT PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 900 EGYPT PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 901 EGYPT PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 902 EGYPT PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 903 EGYPT PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 904 EGYPT PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 905 EGYPT PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 906 EGYPT PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 907 EGYPT PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 908 EGYPT PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 909 EGYPT PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 910 EGYPT PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 911 ISRAEL PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 912 ISRAEL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 913 ISRAEL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 914 ISRAEL SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 915 ISRAEL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 916 ISRAEL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 917 ISRAEL OPTICAL IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 918 ISRAEL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

TABLE 919 ISRAEL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (VOLUME)

TABLE 920 ISRAEL PRECLINICAL NUCLEAR IMAGING SYSTEMS IN PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (ASP)

TABLE 921 ISRAEL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 922 ISRAEL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 923 ISRAEL PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 924 ISRAEL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 925 ISRAEL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 926 ISRAEL PRECLINICAL OPTICAL IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 927 ISRAEL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 928 ISRAEL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 929 ISRAEL PRECLINICAL NUCLEAR IMAGING REAGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 930 ISRAEL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 931 ISRAEL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 932 ISRAEL PRECLINICAL MRI CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 933 ISRAEL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (USD THOUSAND)

TABLE 934 ISRAEL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (VOLUME)

TABLE 935 ISRAEL PRECLINICAL CT CONTRAST AGENTS IN PRECLINICAL IMAGING MARKET, BY REAGENTS, 2021-2030 (ASP)

TABLE 936 ISRAEL PRECLINICAL IMAGING MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 937 ISRAEL PRECLINICAL IMAGING MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 938 REST OF MIDDLE EAST AND AFRICA PRECLINICAL IMAGING MARKET, BY PRODUCT, 2021-2030 (USD THOUSAND)

List of Figure

FIGURE 1 GLOBAL PRECLINICAL IMAGING MARKET: SEGMENTATION

FIGURE 2 GLOBAL PRECLINICAL IMAGING MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL PRECLINICAL IMAGING MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL PRECLINICAL IMAGING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL PRECLINICAL IMAGING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL PRECLINICAL IMAGING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL PRECLINICAL IMAGING MARKET: MARKET END USERS COVERAGE GRID

FIGURE 8 GLOBAL PRECLINICAL IMAGING MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL PRECLINICAL IMAGING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL PRECLINICAL IMAGING MARKET: SEGMENTATION

FIGURE 11 RISING PREVALENCE OF CHRONIC DISORDER AND ADVANCEMENTS IN IMAGING TECHNIQUES ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL PRECLINICAL IMAGING MARKET FROM 2023 TO 2030

FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PRECLINICAL MARKET IN 2023 AND 2030

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PRECLINICAL IMAGING MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL PRECLINICAL IMAGING MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL PRECLINICAL IMAGING MARKET

FIGURE 16 GLOBAL PRECLINICAL IMAGING MARKET: BY PRODUCT, 2022

FIGURE 17 GLOBAL PRECLINICAL IMAGING MARKET: BY REAGENTS, 2022

FIGURE 18 GLOBAL PRECLINICAL IMAGING MARKET: BY APPLICATION, 2022

FIGURE 19 GLOBAL PRECLINICAL IMAGING MARKET: BY END USER, 2022

FIGURE 20 GLOBAL PRECLINICAL IMAGING MARKET: BY SNAPSHOT (2022)

FIGURE 21 GLOBAL PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%)

FIGURE 22 NORTH AMERICA PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%)

FIGURE 23 EUROPE PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%)

FIGURE 24 ASIA-PACIFIC PRECLINICAL IMAGING MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

The Preclinical Imaging Market will be worth USD 3,299,734.83 thousand by 2030.
The Preclinical Imaging Market growth rate is 6.3% during the forecast period.
Increasing Technology Advancement in the Field of Imaging & Increasing Number of Investments and Funding in Research and Development are the growth drivers of the Preclinical Imaging Market.
The product, reagents, application, and end-user are the factors on which the Preclinical Imaging Market research is based.
The PerkinElmer Inc., FUJIFILM Visualsonics, Inc, Bruker, Hologic, Inc, Zeiss International, Agilent Technologies, Inc., Hamamatsu Photonics K.K., SOFIE, Cubresa Inc., Vieworks Co., Ltd., LI-COR, Inc., Aspect Imaging Ltd., Berthold Technologies GmbH & Co.KG are the major companies in the Preclinical Imaging Market.